CATALYST PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q2 2011 to Q1 2024.
  • Catalyst Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $86K, a 24.6% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. annual Depreciation for 2023 was $316K, a 124% increase from 2022.
  • Catalyst Pharmaceuticals, Inc. annual Depreciation for 2022 was $141K, a 26.6% decline from 2021.
  • Catalyst Pharmaceuticals, Inc. annual Depreciation for 2021 was $192K, a 109% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $86K +$17K +24.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $69K +$35K +103% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $34K -$63K -64.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $97K +$83K +593% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $14K +$252 +1.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $6.53K -$2.76K -29.7% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q1 2019 $43.7K $13.7K +$5.73K +71.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $38K $12.5K +$5.56K +80.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $32.4K $9.29K -$3.55K -27.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $36K $8.18K -$4.78K -36.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $40.7K $8.02K -$4.94K -38.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $45.7K $6.94K -$5.03K -42% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $50.7K $12.8K +$3.36K +35.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $47.4K $13K +$4.2K +47.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $43.2K $13K -$240 -1.82% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $43.4K $12K +$5.88K +96.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 $37.5K $9.48K -$1.78K -15.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $39.3K $8.76K -$213 -2.37% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $39.5K $13.2K +$5.05K +62% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $34.5K $6.09K -$1.89K -23.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $36.4K $11.3K +$4.02K +55.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $32.3K $8.98K +$2.89K +47.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $29.4K $8.15K +$2.86K +54.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $26.6K $7.97K +$2.27K +39.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $24.3K $7.24K +$1.53K +26.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $22.8K $6.08K +$377 +6.61% Apr 4, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $22.4K $5.29K -$79 -1.47% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $22.5K $5.71K +$3.05K +115% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $19.4K $5.71K +$2.98K +109% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $16.4K $5.71K +$3K +111% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $13.5K $5.36K +$2.56K +91.5% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $10.9K $2.65K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $2.73K -$4.73K -63.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $2.71K -$18.3K -87.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $2.8K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $7.45K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $21K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.